arrow_back Back to App

International Cooperation for Pandemic Drug Development: New Medicines

This act aims to establish a global strategy for collaborating with other countries to develop and commercialize new drugs, including antimicrobials, to combat pandemics. This means citizens can expect faster access to effective treatments during future health threats, enhancing their safety and health protection.
Key points
International Collaboration: The U.S. will enter agreements with foreign countries to jointly develop new drugs for pandemics.
Faster Drug Access: The goal is to accelerate the development and availability of medicines, potentially improving readiness for future pandemics.
Antimicrobial Focus: Special emphasis will be placed on developing drugs that combat bacteria and viruses.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_2036
Sponsor: Rep. Levin, Mike [D-CA-49]
Process start date: 2021-03-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

SUPER BUGS Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_2036.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-03-18.

What are the main provisions?

Key points include:

  • International Collaboration: The U.S. will enter agreements with foreign countries to jointly develop new drugs for pandemics.
  • Faster Drug Access: The goal is to accelerate the development and availability of medicines, potentially improving readiness for future pandemics.
  • Antimicrobial Focus: Special emphasis will be placed on developing drugs that combat bacteria and viruses.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Levin, Mike [D-CA-49].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Foreign Affairs.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health